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Osborn waves during therapeutic hypothermia
in a young ST−ACS patient after out−of−hospital
cardiac arrest
Fala Osborna w trakcie hipotermii terapeutycznej u młodego pacjenta
z ostrym zespołem wieńcowym z uniesieniem odcinka ST, powikłanym
nagłym zatrzymaniem krążenia
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A b s t r a c t
A 37 year-old male patient was admitted to the intensive care unit after an out-of-hospital cardiac arrest due to ventricular
fibrillation in a course of ST-segment elevation acute coronary syndrome. On admission, the patient was unconscious with
a Glasgow Coma Scale (GCS) score of 5. A percutaneous coronary intervention and mild therapeutic hypothermia (HT),
defined as maintaining body temperature between 32°C and 34°C, were performed. During HT on ECG, we observed
Osborn waves, which resolved spontaneously after re-warming. After five days of recovery, the patient scored 15 on GCS and
did not show any neurological deficits.
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INTRODUCTION
Mild hypothermia therapy (HT), defined as maintaining body
temperature within the range of 32°C to 34°C, is a procedure
of great beneficial potential in preserving cardiac and neuro-
logical functions after out-of-hospital cardiac arrest. The worl-
dwide growing acceptance and expanding use of HT empha-
sises the need for it to be better understood. There are certa-
in non-pathological ECG findings, such as Osborn waves,
which may occur during the procedure that physicians must
be aware of so that they do not feel the need to terminate the
HT prematurely [1].
CASE REPORT
A 37 year-old male patient was admitted to the intensive care
unit after an out-of-hospital cardiac arrest due to ventricular
fibrillation (VF) in the course of ST-segment elevation acute
coronary syndrome. Cardiopulmonary resuscitation (CPR) was
initiated immediately by bystanders using an automatic exter-
nal defibrillator. On admission, the patient was unconscious,
scored 5 points on the Glasgow Coma Scale (GCS), and his
blood pressure (BP) was 150/100 mm Hg. A finger blood stick
on site revealed a glucose level of 86 mg/dL. A 12-lead initial
ECG revealed: sinus rhythm 98 bpm, pathological Q waves
in II, III and aVF, ST segment elevation in II, III and aVF by
1.0 mm, and ST segment depression in V2–V6 to 2.0 mm.
The patient was transferred to a catheterisation laboratory,
where coronary angiography showed chronic occlusion of the
right coronary artery and acute occlusion of the intermediate
branch. Primary percutaneous coronary intervention (PCI)
with implantation of a bare metal stent (BMS) to the interme-
diate branch was performed, resulting in complete reperfu-
sion (TIMI 3 flow). Because of haemodynamic and neurolo-
gical status, a decision was made to apply HT procedure. The
procedure was initiated in the cath-lab. The patient was se-
dated, intubated and connected to a respirator (propofol
1–2 mg/kg/h, fentanyl 1–2 mg/kg/h and vercuronium bromide
www.kardiologiapolska.pl
Therapeutic hypothermia in patient after cardiac arrest
89
0.01–0.05 mg/kg/min). External cooling mattresses were set
up, and the cooling phase of the procedure was started. After
less than six hours, we achieved desired temperature of
< 34°C and proceeded to the maintenance phase of HT.
The patient’s body temperature was maintained at 33 ± 0.8°C,
HR 45–59 bpm, BP 95/65–120/60 mm Hg, central venous
pressure < 12 mm Hg. On ECG, we observed resolution of
the ST segment depression in precordial leads and manife-
station of Osborn waves in V2–V4 leads (Fig. 1). After 36 ho-
urs, we started to re-warm the patient, obtaining a tempera-
ture of > 35°C in the 48th hour. We witnessed a gradual re-
duction in the amplitude and then a total disappearance of
Osborn waves, sinus rhythm 98 bmp, and BP 125/70 mm Hg.
An echocardiogram showed slight enlargement of the left
ventricle and akinesis of basal and medial segment of the in-
ferior wall. On the fourth day of hospitalisation, sedation was
terminated: the patient was breathing on his own and was
disconnected from the respirator. He was conscious and orien-
ted, with a GCS score of 15. The patient complained of chest
pains, presumably caused by CPR, and headache due to trau-
ma while collapsing during the cardiac arrest. The consulting
neurologist found no deficits in neurological functions in an
examination. Head computed tomography showed no struc-
tural abnormalities. The patient was released home in good
overall condition after 21 days of hospitalisation, with zero
on the Rankine scale, with no further neurological deficits
and neither cardiac nor other symptoms.
DISCUSSION
The International Liaison Committee on Resuscitation re-
commends using HT (32°C to 34°C for 12–24 hours) in un-
conscious patients with spontaneous circulation after out-
of-hospital cardiac arrest due to VF [2]. It has been shown in
both clinical and experimental models that such treatment
shows beneficial neuroprotective and cardioprotective pro-
perties.
In heart muscle, HT seems to reduce the infarct size
and metabolic demand of the myocardium, to increase cel-
lular and mitochondrial membrane integrity and stability,
and to improve myocardial microvascular blood flow [3].
The influence of HT on electrical activity of the heart musc-
le is apparent due to certain ECG findings, which may occur
during HT. It appears to have a potential of giving significant
prolongation of PR and QTc intervals, heart rate decrease,
mild arrhythmia and, rarely, VF (especially when associated
with low potassium levels) [4]. But the most obscure fin-
ding, which emerged also in our patient, is the Osborn wave
(J waves) defined as a late delta wave seen at the end of the
QRS complex (or as a small secondary R wave (R’). Named
after John J. Osborn, who described it first in 1953 [5], the
Osborn wave seems to be caused by action potential of
M and epicardial cells, mediated by a transient outward cur-
rent (Ito) that does not occur in the endocardium, originating
in a transmural voltage gradient responsible for the spike-
and-dome morphology of the end of the QRS complex [6].
Figure 1. Osborn waves during hypothermia therapy
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An Osborn wave can occur in hypothermia as well as in
hypercalcaemia. In our patient, we observed the waves in
the V2–V4 leads, when the body temperature dropped be-
low 34°C. After re-warming, the patient’s Osborn wave re-
solved spontaneously.
The second, but equally important, action of HT is neuro-
protection. It has been proven that HT modifies cerebral meta-
bolism of oxygen and glucose, reduces brain oedema, and lo-
wers the risk of thrombosis and epileptic activity through electri-
cal stabilising properties [3]. Most importantly, it is also associa-
ted with an improvement in neurological outcome and 6-month
survival after cardiac arrest due to VF [7]. Our patient was bro-
ught to the clinic unconscious with a GCS score of 5, which
meets the criteria of severe brain injury. After HT and five days of
recovery, his re-evaluated GCS score was 15 and he showed no
neurological deficits at all. The applied treatment brought about
a tremendous improvement in the patient’s health condition and
long-term prognosis. HT presumably helped prevent him from
suffering physical and neurological disability.
The growing use of HT is fuelling expectations and giving
rise to new treatment options in difficult cases such as pa-
tients with out-of-hospital cardiac arrests. But it requires up-
to-date knowledge and understanding of its mechanisms from
the applying physician.
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